Lucy Mosquera, Director of Data Science, Replica Analytics
This webinar hosted by C-Path provides an introduction to synthetic data generation – what it means, how it works and what technologies are used – as well as an overview of use cases where synthetic data can provide value in the context of RWD and clinical trial data.
Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.